MedTrace Logo

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

NCT02378337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2017-11-28

No results posted yet for this study

Summary

Identify the best combination of predictive variables that influence ionizing radiation dose and improved image quality through analysis and quantification of PET-CT images in simulators and patients.

Conditions

  • Malignant Neoplasm of Breast
  • Hodgkin Disease
  • Non-Hodgkin Lymphoma, Follicular (Nodular)
  • Malignant Neoplasm of Bronchus and Lung
  • Malignant Neoplasm of Colon
  • Secondary Neoplasm Malignant and Unspecified Lymph Nodes
  • Malignant Melanoma of the Skin
  • Malignant Neoplasm of Small Intestine

Interventions

OTHER

Image quantify

Will be observed all patients who perform PET / CT examinations, independent of clinical indication, in nuclear medicine at Hospital Sao Rafael. Those who show interest in participating in the study, will be provided free and informed consent form (ICF) for your appreciation. This evaluation will serve for analysis and quantification of PET-CT images.

Sponsors & Collaborators

  • Hospital Sao Rafael

    lead OTHER

Principal Investigators

  • Milena BP Soares, PhD · Hospital São Rafael

  • Vinicius O Menezes, BSc · Hospital São Rafael

  • Marcos AD Machado, BSc · Hospital São Rafael

  • Cleiton C Queiroz, BSc · Hospital São Rafael

  • Mauro Namias, MSc · Fundacion Centro Diagnostico Nuclear

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-08-31
Completion
2016-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02378337 on ClinicalTrials.gov